No detectable untoward consequences on nonneoplastic cells, in vitro. Although it blocks competitively the binding of dihydrotestosterone (DHT) to its protein receptor, it has no major consequences on either estrogen or progesterone receptors. CPC 10997 was discovered for being more effective versus carcinomas of the breast, the kidney, the ovary https://shintarob332oal5.tdlwiki.com/user